Survival Outcomes In Phase I Trial Combining Vcn-01 And Durvalumab (Medi4736) In Subjects With Recurrent/Metastatic Head And Neck Squamous Cell Carcinoma Refractory To Previous Immunotherapy Treatment
Durvalumab;VCN-01
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Survival Outcomes In Phase I Trial Combining Vcn-01 And Durvalumab (Medi4736) In Subjects With Recurrent/Metastatic Head And Neck Squamous Cell Carcinoma Refractory To Previous Immunotherapy Treatment ### Output: Durvalumab;VCN-01